TYENNE
Formula & Concentration
TYENNE – tocilizumab-aazg 162 mg/0.9 mL subcutaneous syringe
Manufacturer
Fresenius Kabi, LLC
Indications
systemic-onset juvenile idiopathic arthritis; polyarticular juvenile idiopathic arthritis; giant cell arteritis; cytokine release syndrome; adjunct tx for COVID-19 requiring oxygen or ventilation; rheumatoid arthritis
Shelf Life and Storage
Fridge (2-8°C)